VCU Massey Cancer Center | Strategic Alliance Partners
A National Cancer Institute-designated cancer center in Richmond, Va., VCU Massey Cancer Center conducts basic, translational, clinical and population sciences cancer research, provides state-of-the-art treatments and clinical trials, and promotes cancer prevention and education. Since 1974, Massey has served as an internationally recognized center of excellence. Its 1,000-plus researchers, clinicians and staff members are dedicated to improving the quality of human life by developing and delivering effective means to prevent, control and ultimately cure cancer.
Latest from VCU Massey Cancer Center
Dr. Geyer on Challenges in HER2+ Metastatic Breast Cancer Management
September 19th 2019Charles E. Geyer, Jr, MD, professor of medicine, Virginia Commonwealth University School of Medicine; associate director for clinical research and Harrigan, Haw, Luck Families chair in Cancer Research, Massey Cancer Center, discusses ongoing challenges in the management of patients with metastatic HER2-positive breast cancer.
Dr. Geyer on Impact of Targeted Agents in HER2+ Breast Cancer
January 22nd 2019Charles E. Geyer, Jr, MD, professor of medicine, Virginia Commonwealth University School of Medicine; associate director for clinical research and Harrigan, Haw, Luck Families chair in Cancer Research, Massey Cancer Center, discusses the impact of targeted agents in HER2-positive breast cancer.
Dr. Geyer Discusses Pertuzumab in HER2+ Breast Cancer
December 29th 2018Charles E. Geyer, Jr, MD, professor of medicine, Virginia Commonwealth University School of Medicine; associate director for clinical research and Harrigan, Haw, Luck Families chair in Cancer Research, Massey Cancer Center, discusses pertuzumab in HER2-positive breast cancer.
Dr. Geyer on the Rationale for the KATHERINE Trial in HER2-Positive Breast Cancer
December 11th 2018Charles E. Geyer, Jr, MD, professor of medicine, Virginia Commonwealth University School of Medicine; associate director for clinical research and Harrigan, Haw, Luck Families chair in Cancer Research, Massey Cancer Center, discusses the rationale and results of the phase III KATHERINE trial in HER2-positive breast cancer.
VCU Explores Novel Combos for Solid Tumors
July 3rd 2017Studies conducted at VCU Massey Cancer Center in Richmond, Virginia, over the past 7 years have developed the therapeutic combination of pemetrexed and sorafenib (Nexavar) from the bench to the bedside, and now into phase II clinical trial evaluation.
BCL-2 Inhibitors May Provide Avenue of Attack Against High-Risk Neuroblastoma
April 17th 2017Investigators at Virginia Commonwealth University Massey Cancer Center discuss the current treatment for children with high-risk neuroblastoma including high-dose chemotherapy, surgery, stem cell transplantation, radiation therapy, isotretinoin, and immunotherapy.
Computer Model Personalizes Donor Selection for Stem Cell Transplants
August 31st 2016Investigators at Virginia Commonwealth University Massey Cancer Center are developing dynamical models that may allow clinicians to move beyond simple human leukocyte antigen matching to personalize immunosuppressive regimens and thus improve donor selection.
Diffusion-Weighted MRI Studies Explored at VCU Massey Cancer Center
March 14th 2016The Department of Radiation Oncology at Virginia Commonwealth University Massey Cancer Center has long been at the forefront worldwide in the development of various radiation therapy technologies that are now considered standard and have become widely available.
Olaparib Studies Put Focus on BRCA-Positive Breast Cancers
January 30th 2016The identification of the BRCA1 and BRCA2 tumor suppressor genes and the recognition that inherited loss of function (deleterious) mutations in one of these important genes places women at high risk for the development of breast, ovarian, and other cancers are major advances in women’s health research.
VCU Massey Cancer Center Joins OncLive's® Strategic Alliance Partnership Program
OncLive® announced an addition to its vibrant Strategic Alliance Partnership program today as VCU Massey Cancer Center signed onto the program's mission to raise awareness of cancer treatment and research.
